In vivo activity of in vitro immunized lymphocytes. I. Tumor allograft rejection mediated by in vitro activated mouse thymocytes.
D000230:Adenocarcinoma / Q000276:immunology; D000818:Animals; D000918:Antibody Specificity; D002478:Cells, Cultured; D002859:Chromium Isotopes; D003348:Cortisone / Q000494:pharmacology; D003601:Cytotoxicity Tests, Immunologic; D005354:Fibrosarcoma / Q000276:immunology; D006084:Graft Rejection; D007111:Immunity, Cellular; D007114:Immunization; D008214:Lymphocytes / Q000276:immunology*; D008223:Lymphoma / Q000276:immunology; D012515:Mast-Cell Sarcoma / Q000276:immunology; D051379:Mice; D009368:Neoplasm Transplantation; D010954:Plasmacytoma / Q000276:immunology; D011828:Radiation Chimera; D013154:Spleen / Q000166:cytology / Q000276:immunology; D013950:Thymus Gland / Q000166:cytology / Q000276:immunology*; D014181:Transplantation Immunology; D014184:Transplantation, Homologous
D002859:Chromium Isotopes; D003348:Cortisone